Contemporary HIV Treatment and Prevention 2022

Download All
Learn from the experts about identifying barriers to PrEP uptake, optimizing ART strategies for patients, incorporating the latest data on emerging and innovative ARV treatment or prevention strategies, and counseling patients on new and investigational ART regimens.
Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Roger Bedimo, MD, MS, FACP
Eric S. Daar, MD
Joseph J. Eron, Jr., MD
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
person default
Christopher Fox, MSN, RN, ANP-BC, AAHIVS
Jasjit Gill, BSPharm, PharmD
Gregory Huhn, MD, MPHTM
Princy N. Kumar, MD, FIDSA, MACP
Daniel R. Kuritzkes, MD
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Paul E. Sax, MD
Babafemi Taiwo, MBBS
David A. Wohl, MD
Darcy Wooten, MD

Video Modules

Hear from expert faculty members as they present nursing insights on some of the most clinically relevant new data presented at CROI 2022, including prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Jasjit Gill, BSPharm, PharmD
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 10, 2022 Expired: May 9, 2023

Listen to expert faculty as they discuss inequities in PrEP uptake in key populations, structural barriers to PrEP adoption, and solutions for expanding PrEP use.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
person default Christopher Fox, MSN, RN, ANP-BC, AAHIVS
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 14, 2022 Expired: June 13, 2023

Hear from expert faculty members as they present some of the most clinically relevant new data presented at CROI 2022 and discuss how they will incorporate the data on prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure strategies into their own practices.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Gregory Huhn, MD, MPHTM Daniel R. Kuritzkes, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: June 17, 2022 Expired: June 16, 2023

Podcasts

Listen to Roger Bedimo, MD, MS, FACP, discuss key considerations for switching ART in virologically suppressed patients who are pregnant or trying to conceive.

Roger Bedimo, MD, MS, FACP Released: October 3, 2022

Downloadable Slidesets

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Released: April 28, 2022

Read expert faculty members’ summaries of cutting-edge concepts in HIV care, including the latest for long-acting therapies and prevention.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Darcy Wooten, MD
Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from CROI 2022, including results from studies of prevention strategies, long-acting therapies, second-line therapies, comorbidities, and cure.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Daniel R. Kuritzkes, MD
Released: May 2, 2022

Read expert faculty summaries on the latest data in first-line ART therapy in diverse patients to assist with individualized ART selection.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Released: April 1, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Gregory Huhn, MD, MPHTM
Released: May 4, 2022

Read expert faculty members’ summaries of state-of-the-art switch strategies in virologically suppressed patients, including switching ART in the setting of resistance, considerations for long acting injectables, and switching ART prior to or during pregnancy.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Paul E. Sax, MD
Released: May 6, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Released: September 22, 2022

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: September 23, 2022

Download slides to review expert insights into strategies for overcoming virologic failure in heavily treatment–experienced patients and selecting optimized switch regimens for virologically suppressed patients with underlying resistance and significant potential drug–drug interactions.

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Eric S. Daar, MD
Released: October 6, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, COVID-19 in PWH, and Monkeypox.

Joseph J. Eron, Jr., MD Jeffrey Kwong, DNP, MPH, FAANP, FAAN Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP David A. Wohl, MD Released: September 23, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, and COVID-19 in PWH.

Jeffrey Kwong, DNP, MPH, FAANP, FAAN Released: September 23, 2022
Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings